The PE Ratio as of December 2024 (TTM) for Ocular Therapeutix, Inc. (OCUL) is -6.50

According to Ocular Therapeutix, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.50. This represents a change of 8.77% compared to the average of -5.98 of the last 4 quarters.

Ocular Therapeutix, Inc. (OCUL) Historical PE Ratio (quarterly & annually)

How has OCUL PE Ratio performed in the past?

The mean historical PE Ratio of Ocular Therapeutix, Inc. over the last ten years is -9.05. The current -6.50 PE Ratio has changed 7.08% with respect to the historical average. Over the past ten years (40 quarters), OCUL's PE Ratio was at its highest in in the March 2021 quarter at 99.99. The PE Ratio was at its lowest in in the September 2023 quarter at -120.75.

Ocular Therapeutix, Inc. (OCUL) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Ocular Therapeutix, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ocular Therapeutix, Inc. (OCUL) Average PE Ratio

How has OCUL PE Ratio performed in the past?

The current PE Ratio of Ocular Therapeutix, Inc. (OCUL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Ocular Therapeutix, Inc. (OCUL) PE Ratio vs. Peers

How is OCUL’s PE Ratio compared to its peers?

Ocular Therapeutix, Inc.’s PE Ratio is less than CytomX Therapeutics, Inc. (6.61), less than Assembly Biosciences, Inc. (-2.29), less than Spero Therapeutics, Inc. (17.30), less than Achilles Therapeutics plc (-0.69), less than Terns Pharmaceuticals, Inc. (-5.07), less than Amylyx Pharmaceuticals, Inc. (-1.05), less than Acumen Pharmaceuticals, Inc. (-1.31), less than Inozyme Pharma, Inc. (-1.91), greater than X4 Pharmaceuticals, Inc. (-7.23), greater than Mereo BioPharma Group plc (-13.71), less than PDS Biotechnology Corporation (-1.50), less than HOOKIPA Pharma Inc. (-0.54), greater than Day One Biopharmaceuticals, Inc. (-14.47),

Build a custom stock screener for Ocular Therapeutix, Inc. (OCUL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ocular Therapeutix, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ocular Therapeutix, Inc. (OCUL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ocular Therapeutix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.